TD-6450
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TD-6450, covering 2017-01-30 to 2017-10-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection [Phase 2]